Page 112 - 《中国药房》2023年24期
P. 112

不同肠内营养制剂用于重症急性胰腺炎的疗效及胃肠道耐受性

          研究
                 Δ


          陈 旭 ,邓 毅 ,李 强 ,吴 迪 (1.电子科技大学医学院附属妇女儿童医院/成都市妇女儿童中心医院药
                           1
                 1*
                                           3 #
                                   2
          学部,成都 611731;2.江苏省人民医院胰腺中心,南京 210029;3.江苏省人民医院药学部,南京 210029)
          中图分类号  R969.3      文献标志码  A      文章编号  1001-0408(2023)24-3046-05
          DOI  10.6039/j.issn.1001-0408.2023.24.16

          摘   要  目的  比较不同肠内营养(EN)制剂用于重症急性胰腺炎(SAP)患者的疗效和胃肠道耐受性。方法  收集 2022 年 1 月 1
          日-2023年6月30日于江苏省人民医院胰腺中心住院治疗的118例SAP患者的临床资料,按使用EN制剂的不同分为短肽类EN
          制剂(SP)组(41例)、不含膳食纤维的整蛋白EN制剂(TP-MCT)组(40例)和含膳食纤维的整蛋白EN制剂(TPF-DM)组(37例)。3
          组患者均鼻饲24 h连续泵注EN制剂,能量目标量均为25~30 kcal/kg。收集3组患者用药前和用药7 d后的血液营养指标[白蛋白
         (ALB)、总蛋白(TP)、血红蛋白(Hb)、球蛋白(GLB)]和炎症指标[白细胞(WBC)、中性粒细胞百分比(N%)、降钙素原(PCT)、C反
          应蛋白(CRP)、白细胞介素6(IL-6)],并汇总其临床结局指标[入住重症监护室(ICU)时间、住院时长、恢复经口饮食时长、病情未
          好转率、死亡率]及胃肠道耐受情况。结果  用药后,3组患者的ALB、TP均显著高于同组用药前(P<0.05);3组患者的CRP、N%,
          TP-MCT组患者的PCT和SP组患者的IL-6均显著低于同组用药前,且TP-MCT组的PCT和SP组的IL-6均显著低于同期的其他
          两组(P<0.05);3组间用药后ALB、TP、CRP、N%比较及3组用药前后的Hb、GLB、WBC比较,差异均无统计学意义(P>0.05)。3
          组患者的临床结局指标比较,差异均无统计学意义(P>0.05)。TP-MCT组患者的胃肠道总不良反应发生率最低(32.50%),且显
          著低于SP组(46.34%)和TPF-DM(48.65%)(P<0.05)。结论  不同EN制剂均能不同程度地改善SAP患者的营养状态并降低炎症
          反应,其中SP和TP-MCT的疗效较显著,且后者的胃肠道耐受性较好。
          关键词  肠内营养;重症急性胰腺炎;疗效;耐受性;不良反应

          Efficacy of different enteral nutrition drugs for severe acute pancreatitis and their gastrointestinal tolerance
                   1
                              1
          CHEN Xu ,DENG Yi ,LI Qiang ,WU Di(1.  Dept.  of  Pharmacy,  the  Affiliated  Women’s  and  Children’s
                                                 3
                                         2
          Hospital,  School  of  Medicine,  University  of  Electronic  Science  and  Technology  of  China/Chengdu  Women’s
          and  Children’s  Central  Hospital,  Chengdu  611731,  China;2.  Pancreatic  Center,  Jiangsu  Provincial  People’s
          Hospital,  Nanjing  210029,  China;3.  Dept.  of  Pharmacy,  Jiangsu  Provincial  People’s  Hospital,  Nanjing
          210029, China)

          ABSTRACT    OBJECTIVE To compare the efficacy of different enteral nutrition (EN) drugs for severe acute pancreatitis (SAP)
          and their gastrointestinal tolerance. METHODS A total of 118 SAP patients admitted to the Pancreatic Center of Jiangsu Provincial
          People’s Hospital from January 1, 2022 to June 30, 2023 were collected and divided into short-peptide EN drugs (SP) group (41
          cases), dietary fiber-free intact protein EN drugs (TP-MCT) group (40 cases) and dietary fiber-containing intact protein EN drugs
         (TPF-DM) group (37 cases) according to the types of EN. All three groups of patients were given continuous pumps of EN drugs
          via  nasal  feeding  for  24  hours,  with  a  target  energy  dose  of  25-30  kcal/kg.  The  blood  nutritional  indexes  [albumin (ALB),  total
          protein (TP),  hemoglobin (Hb),  globulin (GLB)],  inflammation  indexes  [white  blood  cells (WBC),  percentage  of  neutrophils
         (N%),  procalcitonin (PCT),  C-reactive  protein (CRP),  interleukin-6 (IL-6)],  clinical  outcomes  indexes  [time  of  stay  in  the
          intensive care unit (ICU), length of hospital stay, duration of resuming oral diet, the rate of cases without improvement, mortality
          rate]  and  the  occurrence  of  gastrointestinal  tolerance  were  collected  from  3  groups  before  medication  and  7  d  after  medication.
          RESULTS After treatment, ALB and TP in 3 groups were significantly higher than before treatment (P<0.05); CRP and N% of 3
          groups,  PCT  of  TP-MCT  group  and  IL-6  of  SP  group  were  significantly  lower  than  corresponding  group  before  medication (P<
                                                              0.05);  PCT  of  TP-MCT  group  and  IL-6  of  SP  group  were
              Δ 基金项目 江苏省药学会-奥赛康医院药学基金(No.A202101)             significantly  lower  than  those  of  other  two  groups  at
             *第一作者 主管药师,硕士。研究方向:临床药学。E-mail:
                                                              corresponding  period  (P<0.05).  There  were  no  statistical
          84646975@qq.com
              #  通信作者 主 管 药 师 。 研 究 方 向 :临 床 药 学 。 E-mail:    significances  in  ALB,  TP,  CRP  or  N%  among  the  three
          nanjingwudi@126.com                                 groups after medication, and in Hb, GLB or WBC among the


          · 3046 ·    China Pharmacy  2023 Vol. 34  No. 24                            中国药房  2023年第34卷第24期
   107   108   109   110   111   112   113   114   115   116   117